315 related articles for article (PubMed ID: 19889298)
1. [Study and treatment of locally advanced melanoma].
Moreno-Ramírez D; de la Cruz L; Ferrándiz L; Camacho FM
Actas Dermosifiliogr; 2009 Nov; 100(9):767-79. PubMed ID: 19889298
[TBL] [Abstract][Full Text] [Related]
2. Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients.
Takkenberg RB; Vrouenraets BC; van Geel AN; Nieweg OE; Noorda EM; Eggermont AM; Kroon BB
J Surg Oncol; 2005 Aug; 91(2):107-11. PubMed ID: 16028280
[TBL] [Abstract][Full Text] [Related]
3. Isolated limb infusion as palliative treatment for advanced limb disease in patients with AJCC stage IV melanoma.
Kroon HM; Lin DY; Kam PC; Thompson JF
Ann Surg Oncol; 2009 May; 16(5):1193-201. PubMed ID: 19224288
[TBL] [Abstract][Full Text] [Related]
4. Palliation of regional symptoms of advanced extremity melanoma by isolated limb perfusion with melphalan and high-dose tumor necrosis factor.
Fraker DL; Alexander HR; Andrich M; Rosenberg SA
Cancer J Sci Am; 1995; 1(2):122-30. PubMed ID: 9166465
[TBL] [Abstract][Full Text] [Related]
5. Hyperthermic isolation limb perfusion with TNFalpha in the treatment of in-transit melanoma metastasis.
Di Filippo F; Rossi CR; Santinami M; Cavaliere F; Garinei R; Anzà M; Perri P; Botti C; Di Angelo P; Pasqualoni R; Di Filippo S
In Vivo; 2006; 20(6A):739-42. PubMed ID: 17203758
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic hyperthermic limb perfusion in stage I melanoma.
Krige JE; King HS; Strover RM
Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
[TBL] [Abstract][Full Text] [Related]
7. [Extremity perfusion in malignant melanoma].
Hohenberger W; Meyer T; Göhl J
Chirurg; 1994 Mar; 65(3):175-85. PubMed ID: 8194401
[TBL] [Abstract][Full Text] [Related]
8. Surgical management of melanoma.
Wargo JA; Tanabe K
Hematol Oncol Clin North Am; 2009 Jun; 23(3):565-81, x. PubMed ID: 19464603
[TBL] [Abstract][Full Text] [Related]
9. [Surgical treatment and regional chemotherapy in melanoma of the extremities].
Henneking K; Binder J; Weyers W; Schwemmle K
Chirurg; 1993 Feb; 64(2):134-8. PubMed ID: 8462350
[TBL] [Abstract][Full Text] [Related]
10. Isolated limb perfusion for unresectable melanoma of the extremities.
Noorda EM; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Kroon BB
Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572
[TBL] [Abstract][Full Text] [Related]
11. Alternatives for the treatment of local advanced disease: electrochemotherapy, limb perfusion, limb infusion, intralesional IL2. What is the role?
Testori A; Intelisano A; Verrecchia F; Menicanti C; Tosti G; Grassi E; Pari C; Pennacchioli E
Dermatol Ther; 2012; 25(5):443-51. PubMed ID: 23046023
[TBL] [Abstract][Full Text] [Related]
12. [Current aspects in the treatment of malignant melanoma].
Barth A; Cerny T
Schweiz Med Wochenschr; 1994 Sep; 124(36):1592-603. PubMed ID: 7939527
[TBL] [Abstract][Full Text] [Related]
13. [Preventive lymph node excision in the treatment concept of melanoma of the extremities].
Binder J; Henneking K
Zentralbl Chir; 1996; 121(6):474-7. PubMed ID: 8767334
[TBL] [Abstract][Full Text] [Related]
14. Treatment of in-transit metastases from cutaneous melanoma by isolation perfusion with tumour necrosis factor-alpha (TNF-alpha), melphalan and interferon-gamma (IFN-gamma). Dose-finding experience at the National Cancer Institute of Milan.
Vaglini M; Santinami M; Manzi R; Inglese MG; Santoro N; Persiani L; Belli F
Melanoma Res; 1994 Mar; 4 Suppl 1():35-8. PubMed ID: 8038594
[TBL] [Abstract][Full Text] [Related]
15. Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.
Cornett WR; McCall LM; Petersen RP; Ross MI; Briele HA; Noyes RD; Sussman JJ; Kraybill WG; Kane JM; Alexander HR; Lee JE; Mansfield PF; Pingpank JF; Winchester DJ; White RL; Chadaram V; Herndon JE; Fraker DL; Tyler DS;
J Clin Oncol; 2006 Sep; 24(25):4196-201. PubMed ID: 16943537
[TBL] [Abstract][Full Text] [Related]
16. Isolated limb perfusion prolongs the limb recurrence-free interval after several episodes of excisional surgery for locoregional recurrent melanoma.
Noorda EM; Takkenberg B; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Hart GA; Kroon BB
Ann Surg Oncol; 2004 May; 11(5):491-9. PubMed ID: 15078633
[TBL] [Abstract][Full Text] [Related]
17. Hyperthermic isolated limb perfusion with tumor necrosis factor alone for melanoma.
Posner MC; Lienard D; Lejeune FJ; Rosenfelder D; Kirkwood J
Cancer J Sci Am; 1995; 1(4):274-80. PubMed ID: 9166488
[TBL] [Abstract][Full Text] [Related]
18. Phase III adjuvant studies in operable malignant melanoma (review).
Lejeune FJ
Anticancer Res; 1987; 7(4B):701-5. PubMed ID: 3314671
[TBL] [Abstract][Full Text] [Related]
19. [Medical therapy of malignant melanoma].
Mini E; Periti P
Ann Ital Chir; 1989; 60(4):257-63. PubMed ID: 2699710
[No Abstract] [Full Text] [Related]
20. [Cutaneous melanoma].
Eigentler TK; Mügge LO; Bembenek A; Garbe C
Hautarzt; 2007 Oct; 58(10):885-97; quiz 898. PubMed ID: 17973138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
